THE Australian Financial Review has reported that Sigma director Damien Gance has sold a $380 million stake in Sigma Healthcare, having already sold $420 million worth of shares.
Neither Gance nor Sigma responded to the AFR's request for comment.
The news comes as Sigma released its annual report to shareholders yesterday, confirming the results in its preliminary annual report released earlier this year (PD 20 Mar).
It noted a 45.7% jump in statutory net revenues to $4.8 billion for the year-ending 31 Jan, along with a non-recurring after-tax loss due to its merger with Chemist Warehouse.
With the merger now complete, Sigma's financial reporting period will move to the standard 01 Jul to 30 Jun.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 May 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 May 25
